Annual D&A
$89.00 K
-$109.00 K-55.05%
December 31, 2024
Summary
- As of March 12, 2025, SMMT annual depreciation & amortization is $89.00 thousand, with the most recent change of -$109.00 thousand (-55.05%) on December 31, 2024.
- During the last 3 years, SMMT annual D&A has fallen by -$2.37 million (-96.37%).
- SMMT annual D&A is now -97.65% below its all-time high of $3.78 million, reached on January 31, 2010.
Performance
SMMT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$22.00 K
+$2000.00+10.00%
December 31, 2024
Summary
- As of March 12, 2025, SMMT quarterly depreciation & amortization is $22.00 thousand, with the most recent change of +$2000.00 (+10.00%) on December 31, 2024.
- Over the past year, SMMT quarterly D&A has stayed the same.
- SMMT quarterly D&A is now -96.91% below its all-time high of $712.00 thousand, reached on September 30, 2022.
Performance
SMMT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$89.00 K
-$8000.00-8.25%
December 31, 2024
Summary
- As of March 12, 2025, SMMT TTM depreciation & amortization is $89.00 thousand, with the most recent change of -$8000.00 (-8.25%) on December 31, 2024.
- Over the past year, SMMT TTM D&A has stayed the same.
- SMMT TTM D&A is now -96.56% below its all-time high of $2.59 million, reached on September 30, 2022.
Performance
SMMT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
SMMT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.0% | 0.0% | 0.0% |
| 3 y3 years | -96.4% | 0.0% | 0.0% |
| 5 y5 years | -94.6% | 0.0% | 0.0% |
SMMT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -96.4% | at low | -96.9% | +103.4% | -96.6% | +118.3% |
| 5 y | 5-year | -96.4% | at low | -96.9% | +103.4% | -96.6% | +118.3% |
| alltime | all time | -97.7% | +846.8% | -96.9% | +103.4% | -96.6% | +118.3% |
Summit Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $89.00 K(-55.1%) | $22.00 K(+10.0%) | $89.00 K(-8.2%) |
| Sep 2024 | - | $20.00 K(0.0%) | $97.00 K(-11.0%) |
| Jun 2024 | - | $20.00 K(-25.9%) | $109.00 K(-19.3%) |
| Mar 2024 | - | $27.00 K(-10.0%) | $135.00 K(-31.8%) |
| Dec 2023 | $198.00 K(-84.3%) | $30.00 K(-6.3%) | $198.00 K(-140.7%) |
| Sep 2023 | - | $32.00 K(-30.4%) | -$487.00 K(-352.3%) |
| Jun 2023 | - | $46.00 K(-48.9%) | $193.00 K(-73.8%) |
| Mar 2023 | - | $90.00 K(-113.7%) | $738.00 K(-41.6%) |
| Dec 2022 | $1.26 M(-48.6%) | -$655.00 K(-192.0%) | $1.26 M(-51.2%) |
| Sep 2022 | - | $712.00 K(+20.5%) | $2.59 M(+3.2%) |
| Jun 2022 | - | $591.00 K(-3.9%) | $2.51 M(-2.9%) |
| Mar 2022 | - | $615.00 K(-8.3%) | $2.58 M(+5.2%) |
| Dec 2021 | $2.46 M(+22.6%) | $671.00 K(+6.2%) | $2.46 M(+0.6%) |
| Sep 2021 | - | $632.00 K(-5.0%) | $2.44 M(+7.5%) |
| Jun 2021 | - | $665.00 K(+36.6%) | $2.27 M(+11.3%) |
| Mar 2021 | - | $487.00 K(-25.9%) | $2.04 M(+1.8%) |
| Dec 2020 | $2.00 M(+22.3%) | - | - |
| Dec 2020 | - | $657.00 K(+42.2%) | $2.00 M(+48.8%) |
| Sep 2020 | - | $462.00 K(+6.5%) | $1.35 M(-3.2%) |
| Jun 2020 | - | $434.00 K(-3.6%) | $1.39 M(+2.8%) |
| Mar 2020 | - | $450.00 K(-11.0%) | $1.35 M(-28.9%) |
| Dec 2019 | $1.64 M(-16.1%) | - | - |
| Oct 2019 | - | $505.80 K(+27.7%) | $1.90 M(+3.9%) |
| Jul 2019 | - | $396.20 K(-12.5%) | $1.83 M(-3.6%) |
| Apr 2019 | - | $452.60 K(-17.4%) | $1.90 M(-2.8%) |
| Jan 2019 | $1.95 M(+244.8%) | - | - |
| Jan 2019 | - | $547.80 K(+26.3%) | $1.95 M(+6.1%) |
| Oct 2018 | - | $433.60 K(-6.5%) | $1.84 M(+26.4%) |
| Jul 2018 | - | $463.90 K(-8.4%) | $1.46 M(+39.9%) |
| Apr 2018 | - | $506.70 K | $1.04 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | $566.20 K(+681.0%) | - | - |
| Jan 2018 | - | $435.40 K(+783.2%) | $566.20 K(+281.8%) |
| Oct 2017 | - | $49.30 K(+0.2%) | $148.30 K(+26.8%) |
| Jul 2017 | - | $49.20 K(+52.3%) | $117.00 K(+36.4%) |
| Apr 2017 | - | $32.30 K(+84.6%) | $85.80 K(+18.3%) |
| Jan 2017 | $72.50 K(+6.0%) | - | - |
| Jan 2017 | - | $17.50 K(-2.8%) | $72.50 K(+2.3%) |
| Oct 2016 | - | $18.00 K(0.0%) | $70.90 K(-0.1%) |
| Jul 2016 | - | $18.00 K(-5.3%) | $71.00 K(+0.9%) |
| Apr 2016 | - | $19.00 K(+19.5%) | $70.40 K(+2.9%) |
| Jan 2016 | $68.40 K(+37.6%) | - | - |
| Jan 2016 | - | $15.90 K(-12.2%) | $68.40 K(+4.6%) |
| Oct 2015 | - | $18.10 K(+4.0%) | $65.40 K(+11.4%) |
| Jul 2015 | - | $17.40 K(+2.4%) | $58.70 K(+6.9%) |
| Apr 2015 | - | $17.00 K(+31.8%) | $54.90 K(+10.5%) |
| Jan 2015 | $49.70 K(+15.9%) | - | - |
| Jan 2015 | - | $12.90 K(+13.2%) | $49.70 K(+35.1%) |
| Oct 2014 | - | $11.40 K(-16.2%) | $36.80 K(+44.9%) |
| Jul 2014 | - | $13.60 K(+15.3%) | $25.40 K(+115.3%) |
| Apr 2014 | - | $11.80 K | $11.80 K |
| Jan 2014 | $42.90 K(-70.8%) | - | - |
| Jan 2013 | $146.90 K(-50.2%) | - | - |
| Jan 2012 | $295.20 K(-58.5%) | - | - |
| Jan 2011 | $710.50 K(-81.2%) | - | - |
| Jan 2010 | $3.78 M(+38.1%) | - | - |
| Jan 2009 | $2.74 M(-16.5%) | - | - |
| Jan 2008 | $3.28 M(+344.9%) | - | - |
| Jan 2007 | $737.50 K(+206.0%) | - | - |
| Jan 2006 | $241.00 K(+2463.8%) | - | - |
| Jan 2005 | $9400.00 | - | - |
FAQ
- What is Summit Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Summit Therapeutics?
- What is Summit Therapeutics annual D&A year-on-year change?
- What is Summit Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Summit Therapeutics?
- What is Summit Therapeutics quarterly D&A year-on-year change?
- What is Summit Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Summit Therapeutics?
- What is Summit Therapeutics TTM D&A year-on-year change?
What is Summit Therapeutics annual depreciation & amortization?
The current annual D&A of SMMT is $89.00 K
What is the all time high annual D&A for Summit Therapeutics?
Summit Therapeutics all-time high annual depreciation & amortization is $3.78 M
What is Summit Therapeutics annual D&A year-on-year change?
Over the past year, SMMT annual depreciation & amortization has changed by -$109.00 K (-55.05%)
What is Summit Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of SMMT is $22.00 K
What is the all time high quarterly D&A for Summit Therapeutics?
Summit Therapeutics all-time high quarterly depreciation & amortization is $712.00 K
What is Summit Therapeutics quarterly D&A year-on-year change?
Over the past year, SMMT quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Summit Therapeutics TTM depreciation & amortization?
The current TTM D&A of SMMT is $89.00 K
What is the all time high TTM D&A for Summit Therapeutics?
Summit Therapeutics all-time high TTM depreciation & amortization is $2.59 M
What is Summit Therapeutics TTM D&A year-on-year change?
Over the past year, SMMT TTM depreciation & amortization has changed by $0.00 (0.00%)